PHARMAVOX
The computed 12-month bankruptcy probability of PHARMAVOX is 0.6% (low). The company has been active since 2011 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
| Active | 14 yrs |
| Locations | 1 |
| Publications | 6 |
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
| Fiscal year | Type | Filed | Reference |
|---|---|---|---|
| 31-03-2025 | volledig | 28-10-2025 | 2025-00550663 |
| 31-03-2024 | volledig | 29-10-2024 | 2024-00517581 |
| 31-03-2023 | volledig | 31-10-2023 | 2023-00498946 |
| 31-03-2022 | volledig | 10-10-2022 | 2022-20455598 |
| 31-03-2021 | volledig | 03-11-2021 | 2021-75700235 |
| 31-03-2020 | volledig | 10-11-2020 | 2020-69700297 |
| 31-03-2019 | volledig | 23-05-2019 | 2019-14500484 |
| 31-03-2018 | micro | 17-10-2018 | 2018-69600093 |
| 31-03-2017 | volledig | 25-10-2017 | 2017-67900124 |
| 31-03-2016 | volledig | 25-01-2017 | 2017-02700362 |
Historic, not recently confirmed (5)
-
Not recently confirmedlast confirmed in an act from 2019
2 events
- 01-05-2019 Mandate renewed· Director
- 01-07-2015 Appointed· Manager
-
Not recently confirmedlast confirmed in an act from 2019
-
Not recently confirmedlast confirmed in an act from 2015
-
Not recently confirmedlast confirmed in an act from 2015
-
Not recently confirmedlast confirmed in an act from 2015
Former directors (2)
-
Former- → 10-11-2025
-
Former- → 10-11-2025
| NACE primary | Overige zakelijke dienstverlening, neg(82990) |
| Legal form | Private limited company(610) |
| Incorporation | 07-12-2011 |
| Status | Active |
| Postal code | 1170 |
Each band states what its claims rest on. A board seat is influence over the board, not ownership. Court mandates (receiver, interim administrator) and liquidation mandates do not link companies and are therefore absent here; they belong under Directors & mandates.
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21652E0053/00H003 | Brussels | 3,732 m² | 1 · 955 m² | 29.5 m · 8 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
22-01-2026 2 resigning
- Alfred Bourély, Bestuurder
- Juliet Bourély, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Alfred Bour\u00E9ly",
"address": null,
"birth_date": null
},
"effective_date": "2025-11-10",
"evidence_quote": "Prendre acte de la d\u00E9mission recue le 10 novembre 2025 d\u0027Alfred Bour\u00E9ly de son poste d\u0027administrateur de la soci\u00E9t\u00E9, avec effet imm\u00E9diat et sans compensation.",
"discharge_granted": false
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Juliet Bour\u00E9ly",
"address": null,
"birth_date": null
},
"effective_date": "2025-11-10",
"evidence_quote": "Proposer la r\u00E9vocation ad nutum et sans compensation du poste d\u0027administrateur de Juliet Bour\u00E9ly, avec effet imm\u00E9diat.",
"discharge_granted": false
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0841.606.444",
"name_full": "PHARMAVOX",
"legal_form": "SRL"
}
}28-03-2024 Registered office moved within Watermael-Boitsfort
- avenue du Dirigeable 8, 1170 Watermael-Boitsfort → Chaussée de La Hulpe 178, 1170 Watermael-Boitsfort
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "statutaire",
"new_address": {
"city": "Watermael-Boitsfort",
"region": "Brussels",
"street": "Chauss\u00E9e de La Hulpe",
"country": "BE",
"postcode": "1170",
"box_number": null,
"street_number": "178"
},
"old_address": {
"city": "Watermael-Boitsfort",
"region": "Brussels",
"street": "avenue du Dirigeable",
"country": "BE",
"postcode": "1170",
"box_number": null,
"street_number": "8"
},
"effective_date": "2024-02-05",
"evidence_quote": "Le si\u00E8ge social de la soci\u00E9t\u00E9 est transf\u00E9r\u00E9 178 Chauss\u00E9e de La Hulpe, 1170 Watermael-Boitsfort ainsi que l\u0027unit\u00E9 d\u0027\u00E9tablissement reprise sous le num\u00E9ro d\u0027entreprse 2.206.105.840. Ce changement prend effet \u00E0 compter du 5 F\u00E9vrier 2024."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0841.606.444",
"name_full": "PHARMAVOX",
"legal_form": "SRL"
}
}12-03-2020 Capital decrease of €10,000,000
Technical details
{
"events": [
{
"kind": "capital_decrease",
"amount": 10000000.0,
"currency": "EUR",
"after_eur": null,
"delta_eur": -10000000.0,
"before_eur": null,
"amount_type": "kapitaal_effectief",
"effective_date": "2020-02-27",
"evidence_quote": "conseil d\u0027administration a d\u00E9cid\u00E9 de proc\u00E9der au rachat de dix mille (10.000) actions propres en vue de leur annulation imm\u00E9diate par imputation sur les r\u00E9serves disponibles, \u00E0 concurrence de mille euros (1.000,00 EUR) par action, soit un montant global de dix millions d\u2019euros (10.000.000,00 EUR).",
"contribution_type": null
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0841.606.444",
"name_full": "PHARMAVOX",
"legal_form": "SRL"
}
}08-08-2019 Transaction in capital or shares
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0841.606.444",
"name_full": "PHARMAVOX",
"legal_form": "SRL"
}
}17-05-2019 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": false,
"object_change": false,
"effective_date": "2019-05-17",
"legal_form_change": false
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0841.606.444",
"name_full": "PHARMAVOX",
"legal_form": "SPRL"
},
"signature_regime": null,
"special_mandates": [],
"governance_change": {
"admin_delegated_added": []
}
}16-10-2015 4 directors appointed
- Bourely Juliet, Zaakvoerder
- Bourely Gabrielle, Zaakvoerder
- Bourely Michel, Zaakvoerder
- Bourely Alfred, Zaakvoerder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "zaakvoerder",
"person": {
"rrn": null,
"name": "Bourely Juliet",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0507761643",
"name": "BYJULIET SPRL",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2015-07-01",
"evidence_quote": "L\u0027Assembl\u00E9e g\u00E9n\u00E9rale confirme la nomination des quatre nouveaux g\u00E9rants avec effet au 1 juillet 2015: BYJULIET SPRL, BCE 0507.761.643, domicili\u00E9e \u00E0 Avenue du Dirigeable 8, 1170 Watermael-Boitsfort, repr\u00E9sent\u00E9e par Mademoiselle Bourely Juliet, domicili\u00E9e \u00E0 1190 Forest, rue du Zodiaque 40."
},
{
"kind": "director_in",
"role": "zaakvoerder",
"person": {
"rrn": null,
"name": "Bourely Gabrielle",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0507761445",
"name": "BELGABY SPRL",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2015-07-01",
"evidence_quote": "L\u0027Assembl\u00E9e g\u00E9n\u00E9rale confirme la nomination des quatre nouveaux g\u00E9rants avec effet au 1 juillet 2015: BELGABY SPRL, BCE 0507.761.445, domicili\u00E9e \u00E0 Avenue du Dirigeable 8, 1170 Watermael-Boitsfort, repr\u00E9sent\u00E9e par Mademoiselle Bourely Gabrielle, domicili\u00E9e \u00E0 1190 Forest, rue du Zodiaque 40."
},
{
"kind": "director_in",
"role": "zaakvoerder",
"person": {
"rrn": null,
"name": "Bourely Michel",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0507762138",
"name": "BILIVIT SPRL",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2015-07-01",
"evidence_quote": "L\u0027Assembl\u00E9e g\u00E9n\u00E9rale confirme la nomination des quatre nouveaux g\u00E9rants avec effet au 1 juillet 2015: BILIVIT SPRL, BCE 0507.762.138, domicili\u00E9e \u00E0 Avenue du Dirgeable 8, 1170 Watermael-Boitsfort, repr\u00E9sent\u00E9e par Monsieur Bourely Michel, domicili\u00E9e \u00E0 1190 Forest, rue du Zodiaque 40."
},
{
"kind": "director_in",
"role": "zaakvoerder",
"person": {
"rrn": null,
"name": "Bourely Alfred",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0507761841",
"name": "ALBYORIX SPRL",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2015-07-01",
"evidence_quote": "L\u0027Assembl\u00E9e g\u00E9n\u00E9rale confirme la nomination des quatre nouveaux g\u00E9rants avec effet au 1 juillet 2015: ALBYORIX SPRL, BCE 0507.761.841, domicili\u00E9e \u00E0 Avenue du Dingeable 8, 1170 Watermael-Boitsfort, repr\u00E9sent\u00E9e par Monsieur Bourely Alfred, domicili\u00E9e \u00E0 1190 Forest, rue du Zodiaque 40."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0841.606.444",
"name_full": "PHARMAVOX",
"legal_form": "SPRL"
}
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | PHARMAVOX |